{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:04:16Z","timestamp":1794243856454,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yexmp.2025.104982","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:37:50Z","timestamp":1752568670000},"page":"104982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy"],"prefix":"10.1016","volume":"143","author":[{"given":"Qingqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2025.104982_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104982_bb0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexmp.2025.104982_bb0020","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1038\/s41467-024-49885-8","article-title":"Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response","volume":"15","author":"Coulton","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2025.104982_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175445","article-title":"Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer","volume":"134","author":"Dussold","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2025.104982_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042407","article-title":"Primary human M2 macrophage subtypes are distinguishable by aqueous metabolite profiles","volume":"25","author":"Fuchs","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2025.104982_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104982_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104982_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","article-title":"Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma","volume":"9","author":"He","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.yexmp.2025.104982_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12964-023-01424-6","article-title":"Macrophage barrier in the tumor microenvironment and potential clinical applications","volume":"22","author":"Ji","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexmp.2025.104982_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301471","article-title":"Blocked autophagy is involved in layered double hydroxide-induced repolarization and immune activation in tumor-associated macrophages","volume":"12","author":"Jing","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.yexmp.2025.104982_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of tumor-associated macrophages: a therapeutic perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2025.104982_bb0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2025.104982_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166487","article-title":"Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0080","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: can we be more clever than cancer cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14728214.2025.2504376","article-title":"Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers","volume":"30","author":"Li","year":"2025","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.yexmp.2025.104982_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40164-024-00549-9","article-title":"The next frontier in immunotherapy: potential and challenges of CAR-macrophages","volume":"13","author":"Li","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070865","article-title":"Immunotherapies targeting tumor-associated macrophages (TAMs) in Cancer","volume":"16","author":"Li","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexmp.2025.104982_bb0100","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-932-2","article-title":"Targeting macrophages in cancer immunotherapy: frontiers and challenges","volume":"S2090","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.yexmp.2025.104982_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150697","article-title":"Reprogramming tumor-associated macrophages using exosomes from M1 macrophages","volume":"733","author":"Mahmoudi","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexmp.2025.104982_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73624-w","article-title":"M1 macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer","volume":"10","author":"Oshi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2025.104982_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.yexmp.2025.104982_bb0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2025.104982_bb0125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2025.104982_bb0130","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00011-024-01907-3","article-title":"Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization","volume":"73","author":"Sezginer","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.yexmp.2025.104982_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295684","article-title":"Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs","volume":"14","author":"Shao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36839","article-title":"Tumor-associated macrophages within the immunological milieu: an emerging focal point for therapeutic intervention","volume":"10","author":"Shao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexmp.2025.104982_bb0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps - myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.yexmp.2025.104982_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12967-024-05552-6","article-title":"Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy","volume":"22","author":"Su","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexmp.2025.104982_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113343","article-title":"New insights from the single-cell level: tumor associated macrophages heterogeneity and personalized therapy","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2025.104982_bb0165","article-title":"Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104982_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7263358","article-title":"Single-cell RNA sequencing identifies crucial genes influencing the polarization of tumor-associated macrophages in liver cancer","volume":"2024","author":"Xu","year":"2024","journal-title":"Int. J. Genomics"},{"key":"10.1016\/j.yexmp.2025.104982_bb0185","article-title":"The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.104982_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6757898","article-title":"Metastasis-associated protein 1 is involved in angiogenesis after transarterial chemoembolization treatment","volume":"2017","author":"Xue","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexmp.2025.104982_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37192","article-title":"Shaping the immune landscape: multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration","volume":"10","author":"Xue","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexmp.2025.104982_bb0200","doi-asserted-by":"crossref","first-page":"e658","DOI":"10.1002\/mco2.658","article-title":"Macrophage plasticity: signaling pathways, tissue repair, and regeneration","volume":"5","author":"Yan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.yexmp.2025.104982_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216610","article-title":"Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: the intratumor heterogeneity, functional phenotypes, and cellular interactions","volume":"584","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2025.104982_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2025.104982_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2025.104982_bb0220","article-title":"Tumor-associated macrophage subsets: shaping polarization and targeting","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2025.104982_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2025.104982_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2276314","article-title":"Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment","volume":"15","author":"Zhou","year":"2023","journal-title":"Gut Microbes"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:21:12Z","timestamp":1769044872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0014480025000322"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104982","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.104982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104982"}}